GLOW Blend
The GLOW blend
GLOW is a Resolve formulation that brings three well-studied research peptides together: the copper tripeptide, BPC-157 and TB-500. Like early light on the horizon, it is a combination of familiar elements arranged into something new to study.
- GHK-Cu is the tripeptide glycyl-histidyl-lysine bound to a copper ion, originally identified in human plasma.
- BPC-157 is a fifteen-amino-acid synthetic peptide derived from a protein fraction in gastric juice.
- TB-500 is drawn from the short actin-binding stretch of thymosin beta-4.
Research context
Each ingredient has its own preclinical literature. GHK-Cu has been examined in fibroblast and skin-cell culture with attention to collagen and extracellular-matrix genes. BPC-157 and TB-500 have been investigated in rodent models of soft-tissue repair and cell migration. Studying them together lets a lab ask whether a combined preparation behaves differently from its parts, a question the published record has not yet answered in depth.
Vial or capsules
The grid shows GLOW in two forms. The vial holds the blend as a lyophilized powder, labeled by total peptide content, and is the more flexible option for preparing solutions at a chosen concentration. The capsules divide the same three components into fixed per-capsule amounts, with the capsule count on the label, which simplifies per-unit comparisons.
Related products elsewhere in the catalog: KLOW adds KPV to this trio, and each GLOW component is also sold on its own if your design needs single-compound controls.
Documentation
A multi-component product is only as clear as its paperwork. Before starting, confirm that the lot on your GLOW label lines up with a certificate in the COA / Lab Reports area of this site, and that the report covers all three peptides. Certificates are going up as they are issued; until yours appears, our support team can check it for you.
GLOW is intended for laboratory research use and nothing else.